Free Trial
ASX:PKS

PKS (PKS) Stock Price, News & Analysis

About PKS Stock (ASX:PKS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PKS Holdings Limited, a healthcare technology company, develops and commercializes proprietary subscription based clinical decision support (CDS) systems that automates the human decision-making process in healthcare organizations in Australia and internationally. The company offers RippleDown Expert, an CDS system that provides real-time patient monitoring, alerting, data mining, and reporting capability; and RippleDown Auditor, a knowledge based system that allows various departments within a laboratory, including data entry, billing, and specimen reception to audit data in real-time. It also provides LabQ, a data mining tool; PICQ, an auditing tool used in hospital that assesses every record clinically coded for data quality; RISQ to provide industry benchmark of hospital-acquired complications incidence and underlying data quality; and Codexpert, a web-based eBook application providing the full health-data classification reference for clinical coding of patient episodes. The company serves customers through direct sales and channel partners. The company was formerly known as QPro Holdings Limited. PKS Holdings Limited was founded in 1996 and is headquartered in Redfern, Australia.

Receive PKS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PKS and its competitors with MarketBeat's FREE daily newsletter.

PKS Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

PKS Stock Analysis - Frequently Asked Questions

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
ASX:PKS
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$5.97 million
Price / Cash Flow
N/A
Book Value
A$0.16 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (ASX:PKS) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners